{"id":6442,"date":"2025-03-24T02:32:41","date_gmt":"2025-03-24T02:32:41","guid":{"rendered":"https:\/\/onetiger.com\/?p=6442"},"modified":"2025-03-24T02:33:18","modified_gmt":"2025-03-24T02:33:18","slug":"astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global","status":"publish","type":"post","link":"https:\/\/onetiger.com\/bm\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/","title":{"rendered":"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"6442\" class=\"elementor elementor-6442\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-644e43f e-flex e-con-boxed e-con e-parent\" data-id=\"644e43f\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-67c9655 elementor-widget elementor-widget-text-editor\" data-id=\"67c9655\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"x_MsoNormal\">BEIJING:\u00a0Gergasi farmaseutikal AstraZeneca mengumumkan pelaburan besar bernilai AS$2.5 bilion (RM11.7 bilion) di Beijing dalam tempoh lima tahun akan datang, menandakan komitmen kukuh terhadap ekonomi China dan industri biofarmaseutikal global. Ketua Pegawai Eksekutifnya, Pascal Soriot berkata, pelaburan itu mencerminkan keyakinan terhadap ekosistem inovasi dan bakat tempatan.<\/p><p class=\"x_MsoNormal\">Perjanjian bersama e-town Beijing turut disertai usaha sama baharu dengan Shenzhen Kangtai untuk membangunkan ubat inovatif. Soriot menegaskan peranan penting AI dalam mempercepat penghasilan ubat dan menyifatkan China sebagai hab strategik global.<\/p><p class=\"x_MsoNormal\">Langkah ini menyusuli pelaburan terdahulu AstraZeneca bernilai lebih AS$1 bilion di Wuxi dan Qingdao, sekali gus memperkukuh kedudukan China sebagai kuasa saintifik dunia.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>BEIJING:\u00a0Gergasi farmaseutikal AstraZeneca mengumumkan pelaburan besar bernilai AS$2.5 bilion (RM11.7 bilion) di Beijing dalam tempoh lima tahun akan datang, menandakan komitmen kukuh terhadap ekonomi China dan industri biofarmaseutikal global. Ketua Pegawai Eksekutifnya, Pascal Soriot berkata, pelaburan itu mencerminkan keyakinan terhadap ekosistem inovasi dan bakat tempatan. Perjanjian bersama e-town Beijing turut disertai usaha sama baharu dengan [&hellip;]<\/p>","protected":false},"author":1,"featured_media":6448,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[12],"tags":[],"class_list":["post-6442","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global - One Tiger Arena<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/onetiger.com\/bm\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/\" \/>\n<meta property=\"og:locale\" content=\"ms_MY\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global - One Tiger Arena\" \/>\n<meta property=\"og:description\" content=\"BEIJING:\u00a0Gergasi farmaseutikal AstraZeneca mengumumkan pelaburan besar bernilai AS$2.5 bilion (RM11.7 bilion) di Beijing dalam tempoh lima tahun akan datang, menandakan komitmen kukuh terhadap ekonomi China dan industri biofarmaseutikal global. Ketua Pegawai Eksekutifnya, Pascal Soriot berkata, pelaburan itu mencerminkan keyakinan terhadap ekosistem inovasi dan bakat tempatan. Perjanjian bersama e-town Beijing turut disertai usaha sama baharu dengan [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/onetiger.com\/bm\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/\" \/>\n<meta property=\"og:site_name\" content=\"One Tiger Arena\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/onetigerarena\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T02:32:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-24T02:33:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png\" \/>\n\t<meta property=\"og:image:width\" content=\"431\" \/>\n\t<meta property=\"og:image:height\" content=\"117\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin@onetiger\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OneTigerArena\" \/>\n<meta name=\"twitter:site\" content=\"@OneTigerArena\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin@onetiger\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/\"},\"author\":{\"name\":\"admin@onetiger\",\"@id\":\"https:\/\/onetiger.com\/#\/schema\/person\/d1ac10010da2fb5e9aa276e481148c19\"},\"headline\":\"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global\",\"datePublished\":\"2025-03-24T02:32:41+00:00\",\"dateModified\":\"2025-03-24T02:33:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/\"},\"wordCount\":111,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/onetiger.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png\",\"articleSection\":[\"Business\"],\"inLanguage\":\"ms-MY\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/\",\"url\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/\",\"name\":\"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global - One Tiger Arena\",\"isPartOf\":{\"@id\":\"https:\/\/onetiger.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png\",\"datePublished\":\"2025-03-24T02:32:41+00:00\",\"dateModified\":\"2025-03-24T02:33:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#breadcrumb\"},\"inLanguage\":\"ms-MY\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage\",\"url\":\"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png\",\"contentUrl\":\"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png\",\"width\":431,\"height\":117},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/onetiger.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/onetiger.com\/#website\",\"url\":\"https:\/\/onetiger.com\/\",\"name\":\"One Tiger Arena\",\"description\":\"Its a lifestyle not a sport\",\"publisher\":{\"@id\":\"https:\/\/onetiger.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/onetiger.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ms-MY\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/onetiger.com\/#organization\",\"name\":\"One Tiger\",\"alternateName\":\"One Tiger\",\"url\":\"https:\/\/onetiger.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\/\/onetiger.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/onetiger.com\/wp-content\/uploads\/2024\/04\/logo-round.png\",\"contentUrl\":\"https:\/\/onetiger.com\/wp-content\/uploads\/2024\/04\/logo-round.png\",\"width\":1200,\"height\":1200,\"caption\":\"One Tiger\"},\"image\":{\"@id\":\"https:\/\/onetiger.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/onetigerarena\",\"https:\/\/x.com\/OneTigerArena\",\"https:\/\/www.instagram.com\/onetigerarena\/\",\"https:\/\/www.tiktok.com\/@onetigerarena\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/onetiger.com\/#\/schema\/person\/d1ac10010da2fb5e9aa276e481148c19\",\"name\":\"admin@onetiger\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ms-MY\",\"@id\":\"https:\/\/onetiger.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d57229ee75a6352d1afe88951841d5cf5de29e8b4694380eea284dae95ce50ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d57229ee75a6352d1afe88951841d5cf5de29e8b4694380eea284dae95ce50ca?s=96&d=mm&r=g\",\"caption\":\"admin@onetiger\"},\"sameAs\":[\"https:\/\/onetiger.com\"],\"url\":\"https:\/\/onetiger.com\/bm\/author\/adminonetiger\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global - One Tiger Arena","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/onetiger.com\/bm\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/","og_locale":"ms_MY","og_type":"article","og_title":"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global - One Tiger Arena","og_description":"BEIJING:\u00a0Gergasi farmaseutikal AstraZeneca mengumumkan pelaburan besar bernilai AS$2.5 bilion (RM11.7 bilion) di Beijing dalam tempoh lima tahun akan datang, menandakan komitmen kukuh terhadap ekonomi China dan industri biofarmaseutikal global. Ketua Pegawai Eksekutifnya, Pascal Soriot berkata, pelaburan itu mencerminkan keyakinan terhadap ekosistem inovasi dan bakat tempatan. Perjanjian bersama e-town Beijing turut disertai usaha sama baharu dengan [&hellip;]","og_url":"https:\/\/onetiger.com\/bm\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/","og_site_name":"One Tiger Arena","article_publisher":"https:\/\/www.facebook.com\/onetigerarena","article_published_time":"2025-03-24T02:32:41+00:00","article_modified_time":"2025-03-24T02:33:18+00:00","og_image":[{"width":431,"height":117,"url":"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png","type":"image\/png"}],"author":"admin@onetiger","twitter_card":"summary_large_image","twitter_creator":"@OneTigerArena","twitter_site":"@OneTigerArena","twitter_misc":{"Written by":"admin@onetiger","Est. reading time":"1 minit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#article","isPartOf":{"@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/"},"author":{"name":"admin@onetiger","@id":"https:\/\/onetiger.com\/#\/schema\/person\/d1ac10010da2fb5e9aa276e481148c19"},"headline":"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global","datePublished":"2025-03-24T02:32:41+00:00","dateModified":"2025-03-24T02:33:18+00:00","mainEntityOfPage":{"@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/"},"wordCount":111,"commentCount":0,"publisher":{"@id":"https:\/\/onetiger.com\/#organization"},"image":{"@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage"},"thumbnailUrl":"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png","articleSection":["Business"],"inLanguage":"ms-MY","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/","url":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/","name":"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global - One Tiger Arena","isPartOf":{"@id":"https:\/\/onetiger.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage"},"image":{"@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage"},"thumbnailUrl":"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png","datePublished":"2025-03-24T02:32:41+00:00","dateModified":"2025-03-24T02:33:18+00:00","breadcrumb":{"@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#breadcrumb"},"inLanguage":"ms-MY","potentialAction":[{"@type":"ReadAction","target":["https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/"]}]},{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#primaryimage","url":"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png","contentUrl":"https:\/\/onetiger.com\/wp-content\/uploads\/2025\/03\/news-astrazeneca-labur-2billion.png","width":431,"height":117},{"@type":"BreadcrumbList","@id":"https:\/\/onetiger.com\/astrazeneca-labur-as2-5-bilion-di-beijing-perkukuh-dominasi-biofarmaseutikal-global\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/onetiger.com\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca Labur AS$2.5 Bilion di Beijing, Perkukuh Dominasi Biofarmaseutikal Global"}]},{"@type":"WebSite","@id":"https:\/\/onetiger.com\/#website","url":"https:\/\/onetiger.com\/","name":"One Tiger Arena","description":"Its a lifestyle not a sport","publisher":{"@id":"https:\/\/onetiger.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/onetiger.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ms-MY"},{"@type":"Organization","@id":"https:\/\/onetiger.com\/#organization","name":"One Tiger","alternateName":"One Tiger","url":"https:\/\/onetiger.com\/","logo":{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/onetiger.com\/#\/schema\/logo\/image\/","url":"https:\/\/onetiger.com\/wp-content\/uploads\/2024\/04\/logo-round.png","contentUrl":"https:\/\/onetiger.com\/wp-content\/uploads\/2024\/04\/logo-round.png","width":1200,"height":1200,"caption":"One Tiger"},"image":{"@id":"https:\/\/onetiger.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/onetigerarena","https:\/\/x.com\/OneTigerArena","https:\/\/www.instagram.com\/onetigerarena\/","https:\/\/www.tiktok.com\/@onetigerarena"]},{"@type":"Person","@id":"https:\/\/onetiger.com\/#\/schema\/person\/d1ac10010da2fb5e9aa276e481148c19","name":"admin@onetiger","image":{"@type":"ImageObject","inLanguage":"ms-MY","@id":"https:\/\/onetiger.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d57229ee75a6352d1afe88951841d5cf5de29e8b4694380eea284dae95ce50ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57229ee75a6352d1afe88951841d5cf5de29e8b4694380eea284dae95ce50ca?s=96&d=mm&r=g","caption":"admin@onetiger"},"sameAs":["https:\/\/onetiger.com"],"url":"https:\/\/onetiger.com\/bm\/author\/adminonetiger\/"}]}},"_links":{"self":[{"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/posts\/6442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/comments?post=6442"}],"version-history":[{"count":4,"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/posts\/6442\/revisions"}],"predecessor-version":[{"id":6475,"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/posts\/6442\/revisions\/6475"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/media\/6448"}],"wp:attachment":[{"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/media?parent=6442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/categories?post=6442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/onetiger.com\/bm\/wp-json\/wp\/v2\/tags?post=6442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}